2,568
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Delphinidin-3-sambubioside from Hibiscus sabdariffa. L attenuates hyperlipidemia in high fat diet-induced obese rats and oleic acid-induced steatosis in HepG2 cells

, , , & ORCID Icon
Pages 3837-3849 | Received 14 Apr 2021, Accepted 26 Jun 2021, Published online: 20 Jul 2021

References

  • Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–887.
  • Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–1209.
  • Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–1530.
  • Adams LA, Anstee QM, Tilg H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138–1153.
  • He K, Li X, Xiao Y, et al. Hypolipidemic effects of Myrica rubra extracts and main compounds in C57BL/6j mice. Food Funct. 2016;7(8):3505–3515.
  • Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. Jama. 2016;315(22):2424–2434.
  • Zhu KX, Nie SP, Tan LH, et al. A polysaccharide from ganoderma atrum improves liver function in type 2 diabetic rats via antioxidant action and short-chain fatty acids excretion. J Agric Food Chem. 2016;64(9):1938–1944.
  • Chen X, Li X, Zhang X, et al. Antihyperglycemic and antihyperlipidemic activities of a polysaccharide from Physalis pubescens L. in streptozotocin (STZ)-induced diabetic mice. Food Funct. 2019;10(8):4868–4876.
  • Da-Costa-Rocha I, Bonnlaender B, Sievers H, et al. Hibiscus sabdariffa L. - a phytochemical and pharmacological review. Food Chem. 2014;165:424–443.
  • Riaz G, Chopra R. A review on phytochemistry and therapeutic uses of Hibiscus sabdariffa L. Biomed Pharmacother. 2018;102:575–586.
  • Aurelio D-L, Edgardo RG, Navarro-Galindo S. Thermal kinetic degradation of anthocyanins in a roselle (Hibiscus sabdariffa L. cv. ‘Criollo’) infusion. Int J Food Sci Technol. 2008;43(2):322–325.
  • Pan H, Fu C, Huang L, et al. Anti-obesity effect of chitosan oligosaccharide capsules (COSCs) in obese rats by ameliorating leptin resistance and adipogenesis. Mar Drugs. 2018;16(6). DOI:10.3390/md16060198
  • Li Z, Wu YY, Yu BX. Methylophiopogonanone A, an Ophiopogon homoisoflavonoid, alleviates high-fat diet-induced hyperlipidemia: assessment of its potential mechanism. Braz J Med Biol Res. 2020;53(3):e9201.
  • Yu Q, Liu Y, Wu Y, et al. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells. Biomed Pharmacother. 2018;103:1327–1336.
  • Tanaka K, Nakanishi T. Obesity as a risk factor for various diseases: necessity of lifestyle changes for healthy aging. Appl Human Sci. 1996;15(4):139–148.
  • Ojulari OV, Lee SG, Nam JO. Beneficial effects of natural bioactive compounds from hibiscus sabdariffa L. on obesity. Molecules. 2019;24(1). DOI:10.3390/molecules24010210
  • Sheng D, Zhao S, Gao L, et al. BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling. Cell Biosci. 2019;9:77.
  • Mun J, Kim S, Yoon HG, et al. Water extract of curcuma longa L. ameliorates non-alcoholic fatty liver disease. Nutrients. 2019;11:10.
  • Haerer W, Delbaere K, Bartlett H, et al. Relationships between HMG-CoA reductase inhibitors (statin) use and strength, balance and falls in older people. Intern Med J. 2012;42(12):1329–1334.
  • Choi WH, Gwon SY, Ahn J, et al. Cooked rice prevents hyperlipidemia in hamsters fed a high-fat/cholesterol diet by the regulation of the expression of hepatic genes involved in lipid metabolism. Nutr Res. 2013;33(7):572–579.
  • Wang Q, Liu S, Zhai A, et al. AMPK-mediated regulation of lipid metabolism by phosphorylation. Biol Pharm Bull. 2018;41(7):985–993.
  • Li Y, Xu S, Mihaylova MM, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011;13(4):376–388.
  • Esquejo RM, Salatto CT, Delmore J, et al. Activation of liver AMPK with PF-06409577 corrects NAFLD and lowers cholesterol in rodent and primate preclinical models. EBioMedicine. 2018;31:122–132.
  • Garcia D, Hellberg K, Chaix A, et al. Genetic liver-specific AMPK activation protects against diet-induced obesity and NAFLD. Cell Rep. 2019;26(1):192–208.e196.
  • Daval M, Foufelle F, Ferré P. Functions of AMP-activated protein kinase in adipose tissue. J Physiol. 2006;574(Pt 1):55–62.
  • Assifi MM, Suchankova G, Constant S, et al. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am J Physiol Endocrinol Metab. 2005;289(5):E794–800.
  • Huang WC, Chen YL, Liu HC, et al. Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cells. Saudi Pharm J. 2018;26(8):1178–1184.
  • Ziamajidi N, Khaghani S, Hassanzadeh G, et al. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. Food Chem Toxicol. 2013;58:198–209.